世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

メタボロミクス市場：世界の産業動向、シェア、サイズ、成長、機会、2023-2028年予測


Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

市場の概要 世界のメタボロミクス市場規模は、2022年に24億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に11.55%の成長率（CAGR）を示し、2028年までに47億米ドルに達すると予測しています... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
IMARC Services Private Limited.
アイマークサービス 		2023年3月18日 US$2,499
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		143 英語

　

サマリー

市場の概要

世界のメタボロミクス市場規模は、2022年に24億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に11.55%の成長率（CAGR）を示し、2028年までに47億米ドルに達すると予測しています。

メタボロミクスとは、細胞、生体流体、組織、生物における代謝物、または低分子の大規模な研究のことである。様々な生体試料やシステムにおいて、系統的な代謝プロファイリングやフィンガープリントを行うための分析手法である。核磁気共鳴（NMR）分光法や質量分析（MS）などのさまざまな検出技術と、ガスクロマトグラフィーなどの分離技術で構成されています。これらの技術は、メタボローム研究、毒性試験、個別化医療の開発などによく利用されています。また、健康状態の評価や、心血管疾患や神経疾患、がんなどの病気の原因や治療法についての知見を得ることができます。

がんやその他の慢性疾患の有病率の増加は、市場の成長を促進する主要な要因の一つです。さらに、製薬業界の大幅な増加や、個別化医療の需要の高まりも、市場の成長を後押ししています。メタボロミクスは、遺伝子やタンパク質の研究を促進し、医薬品の発見や開発、病気の進行管理に役立つバイオマーカーを開発することができます。さらに、メタボロミクスと機械学習（ML）の統合も、市場の成長を後押ししています。MLは、NMRやMSの技術を用いて生成されたデータの正確な解釈を支援し、複雑で反復的、時間のかかるプロセスを自動化します。また、先進的なMLソフトウェアは、大量のデータを表現するための包括的な分析および可視化機能を提供します。その他、急速な都市化やバイオテクノロジー分野における広範な研究開発（R&D）活動などが、今後数年間、市場を牽引すると予測されます。

主要な市場セグメント：

IMARC Groupは、メタボロミクスの世界市場レポートの各サブセグメントにおける主要動向の分析、および2023年から2028年までの世界、地域、国レベルでの予測を提供します。当レポートでは、製品、適応症、アプリケーションに基づいて市場を分類しています。

製品別構成比：

メタボロミクス機器
メタボロミクスバイオインフォマティクスツールとサービス


表示によるブレークアップ：

がん（Cancer
循環器疾患
神経疾患
先天性代謝異常症（Inborn Errors of Metabolism
その他


アプリケーション別のブレークアップ：

バイオマーカーと創薬
トキシコロジー
ニュートリゲノミクス
個別化医療
その他


地域別構成比：

北アメリカ

ユーエスエー
カナダ


アジア太平洋

中国
日本
インド
南朝鮮
オーストラリア
インドネシア
その他


ヨーロッパ

ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他


ラテンアメリカ

ブラジル
メキシコ
その他


中近東・アフリカ


競合の状況：

また、業界の競争環境についても検討されており、主要なプレーヤーとして、Agilent Technologies Inc.、Biocrates Life Sciences AG、Bio-Rad Laboratories Inc、Bruker Corporation、Danaher Corporation、Human Metabolome Technologies Inc、Metabolon Inc、Shimadzu Corporation、Thermo Fisher Scientific Inc、Waters Corporation、その他があげられています。

本レポートで回答した主な質問

メタボロミクスの世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
主要な地域市場とは？
COVID-19がメタボロミクスの世界市場に与えた影響とは？
製品に基づく市場の内訳は？
適応症に基づく市場の内訳は？
アプリケーションに基づく市場のブレークアップは？
業界のバリューチェーンにおける様々なステージは何か？
業界における主要な推進要因と課題は何か？
メタボロミクスの世界市場の構造と主要プレイヤーは？
業界における競争の度合いはどの程度か？



ページTOPに戻る


目次

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Metabolomics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Metabolomics Instruments
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Metabolomics Bioinformatics Tools and Services
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Indication
    7.1    Cancer
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cardiovascular Disorders
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Neurological Disorders
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Inborn Errors of Metabolism
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Application
    8.1    Biomarker and Drug Discovery
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Toxicology
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Nutrigenomics
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Personalized Medicine
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Competitive Landscape
    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Agilent Technologies Inc.
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Biocrates Life Sciences AG
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
        13.3.3    Bio-Rad Laboratories Inc.
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Bruker Corporation
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
        13.3.5    Danaher Corporation
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    Human Metabolome Technologies Inc.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
        13.3.7    Metabolon Inc.
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
        13.3.8    Shimadzu Corporation
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Thermo Fisher Scientific Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Waters Corporation
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
           13.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Metabolomics Market: Major Drivers and Challenges
Figure 2: Global: Metabolomics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Metabolomics Market: Breakup by Product (in %), 2022
Figure 4: Global: Metabolomics Market: Breakup by Indication (in %), 2022
Figure 5: Global: Metabolomics Market: Breakup by Application (in %), 2022
Figure 6: Global: Metabolomics Market: Breakup by Region (in %), 2022
Figure 7: Global: Metabolomics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Metabolomics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Metabolomics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Metabolomics (Bioinformatics Tools and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Metabolomics (Bioinformatics Tools and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Metabolomics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Metabolomics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Metabolomics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Metabolomics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Metabolomics (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Metabolomics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Metabolomics (Inborn Errors of Metabolism) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Metabolomics (Inborn Errors of Metabolism) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Metabolomics (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Metabolomics (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Metabolomics (Biomarker and Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Metabolomics (Biomarker and Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Metabolomics (Toxicology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Metabolomics (Toxicology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Metabolomics (Nutrigenomics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Metabolomics (Nutrigenomics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Metabolomics (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Metabolomics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Metabolomics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Metabolomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: North America: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: North America: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: United States: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Asia Pacific: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Asia Pacific: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: China: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Europe: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Europe: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Germany: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Latin America: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Latin America: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Brazil: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Middle East and Africa: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Middle East and Africa: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Global: Metabolomics Industry: SWOT Analysis
Figure 81: Global: Metabolomics Industry: Value Chain Analysis
Figure 82: Global: Metabolomics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Metabolomics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Metabolomics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Metabolomics Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 4: Global: Metabolomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Metabolomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Metabolomics Market: Competitive Structure
Table 7: Global: Metabolomics Market: Key Players

　

ページTOPに戻る


　

Summary

Market Overview:

The global metabolomics market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.55% during 2023-2028.

Metabolomics refers to the large-scale study of metabolites, or small molecules, in cells, biofluids, tissues and organisms. It is an analytical approach for systematic metabolic profiling and fingerprinting in various biological samples and systems. It consists of various detection techniques, such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), along with separation techniques, such as gas chromatography. These techniques are commonly used for metabolome studies, toxicology testing and developing personalized medicine. They also provide an assessment of health and an insight into the causes and treatment of medical ailments, such as cardiovascular and neurological diseases and cancer.

The increasing prevalence of cancer and other chronic diseases is one of the key factors driving the growth of the market. Furthermore, a significant increase in the pharmaceutical industry, along with the rising demand for personalized medicines, is also providing a boost to the market growth. Metabolomics facilitates the study of genes and proteins, along with the development of biomarkers that aid in the discovery and development of medicines and managing disease progression. Additionally, the integration of metabolomics with machine learning (ML) is also favoring the market growth. ML aids in the accurate interpretation of data generated using the NMR and MS techniques and automates complex, repetitive and time-consuming processes. Advanced ML software also offers comprehensive analysis and visualization functions for the representation of large amounts of data. Other factors, including rapid urbanization and extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market in the upcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global metabolomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, indication and application.

Breakup by Product:

Metabolomics Instruments
Metabolomics Bioinformatics Tools and Services


Breakup by Indication:

Cancer
Cardiovascular Disorders
Neurological Disorders
Inborn Errors of Metabolism
Others


Breakup by Application:

Biomarker and Drug Discovery
Toxicology
Nutrigenomics
Personalized Medicine
Others


Breakup by Region:

North America

United States
Canada


Asia Pacific

China
Japan
India
South Korea
Australia
Indonesia
Others


Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Others


Latin America

Brazil
Mexico
Others


Middle East and Africa


Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Human Metabolome Technologies Inc., Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Questions Answered in This Report:

How has the global metabolomics market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global metabolomics market?
What is the breakup of the market based on the product?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global metabolomics market and who are the key players?
What is the degree of competition in the industry?



ページTOPに戻る


Table of Contents

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Metabolomics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Metabolomics Instruments
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Metabolomics Bioinformatics Tools and Services
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Indication
    7.1    Cancer
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cardiovascular Disorders
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Neurological Disorders
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Inborn Errors of Metabolism
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Application
    8.1    Biomarker and Drug Discovery
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Toxicology
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Nutrigenomics
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Personalized Medicine
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Competitive Landscape
    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Agilent Technologies Inc.
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Biocrates Life Sciences AG
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
        13.3.3    Bio-Rad Laboratories Inc.
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Bruker Corporation
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
        13.3.5    Danaher Corporation
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    Human Metabolome Technologies Inc.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
        13.3.7    Metabolon Inc.
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
        13.3.8    Shimadzu Corporation
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Thermo Fisher Scientific Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Waters Corporation
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
           13.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Metabolomics Market: Major Drivers and Challenges
Figure 2: Global: Metabolomics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Metabolomics Market: Breakup by Product (in %), 2022
Figure 4: Global: Metabolomics Market: Breakup by Indication (in %), 2022
Figure 5: Global: Metabolomics Market: Breakup by Application (in %), 2022
Figure 6: Global: Metabolomics Market: Breakup by Region (in %), 2022
Figure 7: Global: Metabolomics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Metabolomics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Metabolomics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Metabolomics (Bioinformatics Tools and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Metabolomics (Bioinformatics Tools and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Metabolomics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Metabolomics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Metabolomics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Metabolomics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Metabolomics (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Metabolomics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Metabolomics (Inborn Errors of Metabolism) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Metabolomics (Inborn Errors of Metabolism) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Metabolomics (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Metabolomics (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Metabolomics (Biomarker and Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Metabolomics (Biomarker and Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Metabolomics (Toxicology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Metabolomics (Toxicology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Metabolomics (Nutrigenomics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Metabolomics (Nutrigenomics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Metabolomics (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Metabolomics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Metabolomics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Metabolomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: North America: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: North America: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: United States: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Asia Pacific: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Asia Pacific: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: China: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Europe: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Europe: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Germany: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Latin America: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Latin America: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Brazil: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Middle East and Africa: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Middle East and Africa: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Global: Metabolomics Industry: SWOT Analysis
Figure 81: Global: Metabolomics Industry: Value Chain Analysis
Figure 82: Global: Metabolomics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Metabolomics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Metabolomics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Metabolomics Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 4: Global: Metabolomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Metabolomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Metabolomics Market: Competitive Structure
Table 7: Global: Metabolomics Market: Key Players

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

IMARC Services Private Limited.社の医療分野での最新刊レポート

本レポートと同じKEY WORD（industry）の最新刊レポート


よくあるご質問


IMARC Services Private Limited.社はどのような調査会社ですか?


インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15　10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.